Target intelligence / Profile preview

Innate immune pattern recognition pathways (PRR pathways)

Target
PRR pathways
Molecular classification
Receptor, Enzyme, Transcription factor, Other
01

Overview

Innate immune pattern recognition pathways represent the fundamental sensing systems of the immune system, responsible for detecting conserved molecular signatures of microbes and host distress (Takeuchi & Akira, 2010, Cell). These pathways are mediated by various classes of Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and C-type lectin receptors (CLRs) (Janeway & Medzhitov, 2002, Annu Rev Immunol). When these receptors encounter pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs), they initiate intracellular signaling cascades involving adapters like MyD88 or TRIF (O'Neill et al., 2013, Nat Rev Immunol). This leads to the activation of transcription factors such as NF-κB and IRFs, resulting in the secretion of pro-inflammatory cytokines and type I interferons (Kawai & Akira, 2010, Nat Immunol). While essential for host defense, chronic or inappropriate activation of these pathways contributes to the pathogenesis of autoimmune diseases, metabolic disorders, and cancer (Kopp & Medzhitov, 2003, Curr Opin Immunol). Consequently, these pathways are major targets for drug development, with agonists like Imiquimod used as cancer immunotherapies and antagonists like NLRP3 inhibitors explored for treating chronic inflammatory conditions (Moresco et al., 2011, Nat Immunol).

Other names
Pattern recognition receptor pathwaysInnate immune sensing pathwaysPRR signaling pathwaysInnate immune pattern recognition
02

Mechanism of action

Agonism or antagonism of specific pattern recognition receptors to modulate innate immune signaling and cytokine production.

03

Biological functions

Immune responseInflammationSignal transductionApoptosisAutophagy
04

Disease associations

InfectionInflammationAutoimmune diseaseCancerNeurodegenerative diseaseMetabolic disorder
05

Safety considerations

Cytokine release syndromeSystemic inflammatory response syndrome (SIRS)Exacerbation of autoimmunityInjection site reactionsFlu-like symptoms
06

Interacting drugs

Imiquimod

6 more in the full profile.

07

Biomarkers

Interleukin-1 beta (IL-1B)Tumor necrosis factor alpha (TNF-alpha)Type I Interferons (IFN-alpha/beta)C-reactive protein (CRP)Interleukin-6 (IL-6)

Beyond the preview

Go deeper on Innate immune pattern recognition pathways (PRR pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune pattern recognition pathways (PRR pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call